Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-051916
Filing Date
2014-08-12
Accepted
2014-08-12 17:12:53
Documents
1
Period of Report
2014-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6377
  Complete submission text file 0001209191-14-051916.txt   7885
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 141034736